| Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT ML Sorror, MB Maris, R Storb, F Baron, BM Sandmaier, DG Maloney, ... Blood 106 (8), 2912-2919, 2005 | 2961 | 2005 |
| Reduced mortality after allogeneic hematopoietic-cell transplantation TA Gooley, JW Chien, SA Pergam, S Hingorani, ML Sorror, M Boeckh, ... New England Journal of Medicine 363 (22), 2091-2101, 2010 | 1693 | 2010 |
| Long-term survival and late deaths after allogeneic hematopoietic cell transplantation JR Wingard, NS Majhail, R Brazauskas, Z Wang, KA Sobocinski, ... Journal of clinical oncology 29 (16), 2230-2239, 2011 | 728 | 2011 |
| Comorbidity and disease status–based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell … ML Sorror, BM Sandmaier, BE Storer, MB Maris, F Baron, DG Maloney, ... Journal of Clinical Oncology 25 (27), 4246-4254, 2007 | 472 | 2007 |
| Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation ML Sorror, RF Storb, BM Sandmaier, RT Maziarz, MA Pulsipher, MB Maris, ... Journal of Clinical Oncology 32 (29), 3249-3256, 2014 | 436 | 2014 |
| Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning F Baron, MB Maris, BM Sandmaier, BE Storer, M Sorror, R Diaconescu, ... Journal of clinical oncology 23 (9), 1993-2003, 2005 | 433 | 2005 |
| Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute … RB Walter, TA Gooley, BL Wood, F Milano, M Fang, ML Sorror, EH Estey, ... Journal of clinical oncology 29 (9), 1190-1197, 2011 | 428 | 2011 |
| Cord-blood transplantation in patients with minimal residual disease F Milano, T Gooley, B Wood, A Woolfrey, ME Flowers, K Doney, ... New England Journal of Medicine 375 (10), 944-953, 2016 | 408 | 2016 |
| A disease risk index for patients undergoing allogeneic stem cell transplantation P Armand, CJ Gibson, C Cutler, VT Ho, J Koreth, EP Alyea, J Ritz, ... Blood, The Journal of the American Society of Hematology 120 (4), 905-913, 2012 | 399 | 2012 |
| Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors R Diaconescu, CR Flowers, B Storer, ML Sorror, MB Maris, DG Maloney, ... Blood 104 (5), 1550-1558, 2004 | 389 | 2004 |
| Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of … ML Sorror, MB Maris, B Storer, BM Sandmaier, R Diaconescu, C Flowers, ... Blood 104 (4), 961-968, 2004 | 383 | 2004 |
| Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study ML Green, W Leisenring, HU Xie, TC Mast, Y Cui, BM Sandmaier, ... The Lancet Haematology 3 (3), e119-e127, 2016 | 375 | 2016 |
| Hematopoietic cell transplantation–specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC … ML Sorror, S Giralt, BM Sandmaier, M De Lima, M Shahjahan, ... Blood, The Journal of the American Society of Hematology 110 (13), 4606-4613, 2007 | 362 | 2007 |
| Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning ML Sorror, BE Storer, BM Sandmaier, M Maris, J Shizuru, R Maziarz, ... Journal of Clinical Oncology 26 (30), 4912-4920, 2008 | 361 | 2008 |
| Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies ML Sorror, BM Sandmaier, BE Storer, GN Franke, GG Laport, ... Jama 306 (17), 1874-1883, 2011 | 335 | 2011 |
| Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative … M Sorror, B Storer, BM Sandmaier, DG Maloney, TR Chauncey, ... Cancer 112 (9), 1992-2001, 2008 | 288 | 2008 |
| Late events after treatment with CD19-targeted chimeric antigen receptor modified T cells A Cordeiro, ED Bezerra, AV Hirayama, JA Hill, QV Wu, J Voutsinas, ... Biology of Blood and Marrow Transplantation 26 (1), 26-33, 2020 | 275 | 2020 |
| Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a … BL Scott, BM Sandmaier, B Storer, MB Maris, ML Sorror, DG Maloney, ... Leukemia 20 (1), 128-135, 2006 | 270 | 2006 |
| Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia ML Sorror, MB Maris, BM Sandmaier, BE Storer, MJ Stuart, U Hegenbart, ... Journal of Clinical Oncology 23 (16), 3819-3829, 2005 | 268 | 2005 |
| Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation R Storb, B Gyurkocza, BE Storer, ML Sorror, K Blume, D Niederwieser, ... Journal of Clinical Oncology 31 (12), 1530-1538, 2013 | 266 | 2013 |
